A

Alibaba Health Information Technology Ltd
HKEX:241

Watchlist Manager
Alibaba Health Information Technology Ltd
HKEX:241
Watchlist
Price: 3.45 HKD -0.29% Market Closed
Market Cap: 55.5B HKD
Have any thoughts about
Alibaba Health Information Technology Ltd?
Write Note

Alibaba Health Information Technology Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Alibaba Health Information Technology Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
A
Alibaba Health Information Technology Ltd
HKEX:241
Note Receivable
ÂĄ31.6m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
China Ruyi Holdings Ltd
HKEX:136
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cybernaut International Holdings Co Ltd
HKEX:1020
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
YesAsia Holdings Ltd
HKEX:2209
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hong Kong Technology Venture Co Ltd
HKEX:1137
Note Receivable
HK$60.5m
CAGR 3-Years
5%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Y
Yoho Group Holdings Ltd
HKEX:2347
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Alibaba Health Information Technology Ltd
Glance View

Market Cap
55.4B HKD
Industry
Retail

Alibaba Health Information Technology Ltd., often referred to as Alibaba Health, is a pioneering force in the rapidly evolving realm of digital healthcare. As the healthcare arm of the Alibaba conglomerate, it capitalizes on the group's formidable tech expertise and e-commerce prowess to streamline health services. Its operations stretch across several domains, from pharmaceutical retail to medical services. One of the company's key strengths lies in its online pharmacy platform. Partnering with various pharmaceutical brands, Alibaba Health provides an extensive digital marketplace for medications, health supplements, and medical devices. This platform not only simplifies access for consumers but also integrates data analytics to manage supply chains efficiently, ensuring timely availability of products. Beyond its e-commerce foundation, Alibaba Health is also cultivating a robust digital health ecosystem. It offers telemedicine services where users can consult healthcare professionals via online platforms, a feature that gained significant traction during pandemic-related lockdowns. Moreover, the company dives deep into health management technologies, utilizing artificial intelligence to develop personalized health plans and digital tools for patient monitoring. By harnessing big data, Alibaba Health assists in forming public health decisions and improving patient outcomes. Revenues stream from not just product sales, but also subscription fees and partnerships with health providers and governments alike, positioning the company as a pivotal player in China's push towards a more integrated and efficient healthcare system.

Intrinsic Value
2.54 HKD
Overvaluation 26%
Intrinsic Value
Price
A

See Also

What is Alibaba Health Information Technology Ltd's Note Receivable?
Note Receivable
31.6m CNY

Based on the financial report for Sep 30, 2024, Alibaba Health Information Technology Ltd's Note Receivable amounts to 31.6m CNY.

What is Alibaba Health Information Technology Ltd's Note Receivable growth rate?
Note Receivable CAGR 3Y
46%

Over the last year, the Note Receivable growth was 114%. The average annual Note Receivable growth rates for Alibaba Health Information Technology Ltd have been 46% over the past three years .

Back to Top